Breaking the bonds: targeting protein dimerization for prostate cancer therapy

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Metastatic prostate cancer (PCa) is a leading cause of cancer death.
• Androgen deprivation therapy (ADT) is initially effective but often leads to castration resistance.
• Aberrant protein dimerization drives PCa progression and therapeutic resistance.

Purpose of the Study:

• To review oncogenic dimerization events in PCa.
• To discuss the relevance of dimerization in PCa progression and resistance.
• To explore therapeutic strategies targeting protein dimerization.

Main Methods:

• Literature review of pre-clinical and clinical findings on protein dimerization in PCa.
• Analysis of dimerization's role in key signaling pathways.
• Examination of therapeutic approaches to modulate dimerization.

Main Results:

• Protein-protein interactions, particularly dimerization, are critical in PCa signaling and resistance.
• Similar dimeric interactions are successfully targeted in other cancers.
• Various strategies exist to modulate dimerization with differing efficacies and limitations.

Conclusions:

• Targeting protein dimerization is a promising, underexplored strategy for advanced PCa.
• Disrupting oncogenic dimers could complement existing treatments and overcome resistance.
• Further research is needed to fully realize the therapeutic potential of targeting dimerization in PCa.